When was Pr3vent founded?

Pr3vent was founded in 2017 and raised its 1st funding round 1 year after it was founded.

Where is Pr3vent located?

Pr3vent is headquartered in San Francisco, United States.

How many employees does Pr3vent have?

As of Jun 30, 2026, the latest employee count at Pr3vent is 7.

Is Pr3vent a funded company?

Pr3vent is a funded company, having raised a total of $2.5M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Oct 16, 2018.

When was the latest funding round of Pr3vent?

Pr3vent's latest funding was a $***** Series A round on Feb 12, 2019, with participation from 1 investor.

Where does Pr3vent rank among its competitors?

Pr3vent ranks 14th amongst 89 active competitors, of which 23 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was PeriVision, which secured $3M in Sep, 2025.

Who are the top competitors of Pr3vent?

Pr3vent's top competitors include Remidio, Intelligent Retinal Imaging Systems and PeriVision. Among them, PeriVision secured the most recent funding round in September, 2025.

Pr3vent - 2026 Company Profile, Team, Funding & Competitors

Pr3vent is a series A company based in San Francisco (United States), founded in 2017 by Darius M Moshfeghi. It operates as a Provider of AI-based platform for ophthalmic conditions in newborns. Pr3vent has raised $2.5M in funding from investors like InFocus Capital Partners, Trousdale Ventures and Skyview Ventures. The company has 89 active competitors, including 23 funded and 6 that have exited. Its top competitors include companies like Remidio, Intelligent Retinal Imaging Systems and PeriVision.

Company Details

Provider of AI-based platform for ophthalmic conditions in newborns. The company uses its patented algorithms and screening service for applications in newborn eye screening.

Website: www.pr3vent.com/
Social

Key Metrics

Founded Year

2017

Location

San Francisco, United States

Stage

Series A

Total Funding

$2.5M in 2 rounds

Latest Funding Round

Series A, Feb 12, 2019, $*****

Investors

InFocus Capital Partners & 2 more

Ranked

14^th among 89 active competitors

Employee Count

7 as on Jun 30, 2026

Similar Companies

Remidio & 109 more

View Pr3vent's full profile

Pr3vent has raised a total funding of $2.5M over 2 rounds. Its first funding round was on Oct 16, 2018. Its latest funding round was a Series A round on Feb 12, 2019 for $*****. 1 investor participated in its latest round. Pr3vent has 3 institutional investors.

Here is the list of recent funding rounds of Pr3vent:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 12, 2019	6792373	Series A	8664008	8412878	8702570	1894054
Oct 16, 2018	2323639	Seed	1441570	3616094	Trousdale Ventures & 1 more	5393298

Access funding benchmarks and valuations. Sign up today!

View details of Pr3vent's funding rounds and investors

The founders of Pr3vent is Darius M Moshfeghi.

Here are the details of Pr3vent's key team members:

Darius M Moshfeghi: Co-Founder of Pr3vent.
Contact Info: 1 email address

View details of Pr3vent's Founder profiles and Board Members

Pr3vent's employee count trend

Pr3vent has 7 employees as of Jun 26. Here is Pr3vent's employee count trend over the years:

Uncover Pr3vent's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Pr3vent include Remidio, Intelligent Retinal Imaging Systems and PeriVision. Here is the list of Top 10 competitors of Pr3vent, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Remidio 2009, Bengaluru (India), Series B	Developer of AI-powered portable digital solutions for ophthalmic screening and diagnosis	$25M	Montane Ventures, KITVEN & 32 others	66/100
2nd	Intelligent Retinal Imaging Systems 2011, Pensacola (United States), Acquired	Telemedicine system for the early detection of diabetic eye disease	$13.3M	Ballast Point Ventures, Allumia Ventures & 1 others	60/100
3rd	PeriVision 2019, Epalinges (Switzerland), Seed	SaaS and AI based vision care clinical workflow for professionals and patients	$4.69M	Swiss ICT Investor Club, DART Ventures & 11 others	59/100
4th	Toku Eyes 2018, Auckland (New Zealand), Acquired	Developer of AI-powered retinal image analysis for early disease detection. This company offers tools that analyze retinal images to identify indicators of various health conditions, including cardiovascular risk and chronic kidney disease. The technology utilizes artificial intelligence to provide non-invasive, real-time assessments, potentially enabling earlier diagnosis and intervention. The company's products are subject to varying regulatory approvals depending on the region.	$10.5M	National Vision, Icehouse Ventures & 16 others	56/100
5th	Optain 2023, New York City (United States), Series A	AI-powered retinal imaging technology for non-invasive evaluation of patients	$38M	Insight Partners, Lumio Capital & 8 others	55/100
6th	Heru 2018, Miami (United States), Series A	AI-based medical vision diagnostic device and platform	$36.7M	Open Opportunity Fund, Krillion Ventures & 3 others	55/100
7th	Cassini 2006, The Hague (Netherlands), Series A	Provider of corneal diagnostic solutions	$547K	IPF Partners, Innovation Industries	53/100
8th	AIOptics 2020, New York (United States), Series B	Provider of AI-based digital platform and device to prevent blindness	$14.7M	Octane, HHS	49/100
9th	Topconhealthcare 2018, Oakland (United States), Unfunded	-	-	-	47/100
10th	Oivi 2017, Oslo (Norway), Seed	Online platform for tracking eye diseases through teleconsultation	$500K	Arali Ventures, Skyfall Ventures & 5 others	46/100
14th	Pr3vent 2017, San Francisco (United States), Series A	Provider of AI-based platform for ophthalmic conditions in newborns	$2.5M	Skyview Ventures, InFocus Capital Partners ... & 1 others	42/100